**Specifications Table**TableSubject areaMedicineMore specific subject areaDiabetes, Endocrinology and MetabolismType of dataTablesHow data was acquiredThe data acquired from two endocrinology outpatient clinics affiliated by Islamic Azad University of Mashhad, Iran (IAUM) from January 2016 to September 2017. Study population was adults with non-insulin-using type 2 diabetes mellitus who refused insulin therapy. A 17-items researcher made questionnaire was used to obtain demographic data and information toward causes of insulin refusal.Data formatRaw, analyzedExperimental factorsThe questionnaire consisted of 17 two-way questions. In the test-retest method, the questionnaire was completed by 15 patients and again completed 2 weeks later by the same patients.Experimental featuresMultiple logistic regressions were used to study the association between cause of insulin therapy refusal and some variables including age, gender, marital status, education level, and disease duration.Data source locationMashhad, Razavi Khorasan province, IranData accessibilityData are included in this article

**Value of the data**•Many type 2 diabetes mellitus (T2DM) patients are reluctant to start insulin therapy and may delay beginning it for significant periods of time [@bib1]. Causes of delay are multi-factorial, such as healthcare system barriers and clinical attitudes among healthcare professionals. Delay may also be due to patients experiencing PIR [@bib2].•Refusal or delay for insulin therapy may induce many adverse effects on patients.•While other studies explored patients' attitudes toward insulin therapy, limited data are available regarding patients׳ attitudes prior to treatment.•The data presented in this article shows the factor affecting insulin refusal in poorly controlled T2DM patients prior to insulin therapy.•The data in this article indicates that pain and fear from injection are the most important factors for insulin refusal.•The cost of insulin was recognized as one of the most important factors for insulin refusal.

1. Data {#s0005}
=======

A total of 110 eligible patients were enrolled in this study. The response rate in this study was 100%. Patients' mean age was 56.61 ± 12.19 (33--88) years. Furthermore, 77.3% of patients were female and 73.6% of patients had positive family history for diabetes. The majority of the respondents were married (95.5%), and had only primary education or no formal education (68.2%). 82.7% of the patients had been diagnosed with T2DM for more than ten years. Demographic data are listed in [Table 1](#t0005){ref-type="table"}.Table 1Patients׳ demographic data.Table 1**VariablesFrequencyNumberPercent**GenderFemale8577.3Male2522.7Marital StatusSingle54.5Married10595.5Education LevelLess than Diploma7568.2Diploma2119.1Formal Education1412.7MedicationMetformin2220Metformin plus other agents8280Diabetes Family HistoryPositive8173.6Negative2923.4Diabetes Diagnosis DurationTen years and more9182.7Less than ten years1917.3Total--110100

The causes of insulin refusal according to patients׳ opinion are listed in [Table 2](#t0010){ref-type="table"}. As seen in [Table 2](#t0010){ref-type="table"}, the most prevalent cause of insulin therapy refusal was reported painful insulin injection (78.2%). Second more prevalent reported cause was "I'm afraid of injecting myself with a needle" (74.5%). In our study, 34.5% of patients expressed the cost of insulin therapy as a reason for refusing it.Table 2Causes of insulin refusal according to patients׳ opinion.Table 2**Parameters associated with insulin therapy refusalNumber (%)AgreeDisagree**Taking insulin means I have failed to manage my diabetes with diet and tablets16 (14.5%)94 (85.5%)Taking insulin means other people look at me as a sick person8 (7.3%)102 (92.7%)Taking insulin makes it more difficult to fulfill my responsibilities (at work, at home)6 (5.5%)104 (94.5%)Injecting insulin is painful86 (78.2%)24 (21.8%)Taking insulin is embarrassing10 (9.1%)100 (90.9%)Insulin is expensive38 (34.5%)72 (65.5%)It is difficult to inject the right amount of insulin correctly at the right time every day18 (16.4%)92 (83.6%)Managing insulin injections takes a lot of time6 (5.5%)104 (94.5%)Taking insulin means I have to give up activities I enjoy33 (30%)77 (70%)Taking insulin means my health will deteriorate19 (17.3%)91 (82.7%)Taking insulin decreases my self confidence13 (11.8%)97(88.2%)Taking insulin makes me more dependent on my doctor20 (18.2%)90 (81.8%)Insulin causes weight gain8 (7.3%)102 (92.7%)Being on insulin causes family and friends to be more concerned about me20 (18.2%)90 (81.8%)Taking insulin increases the risk of low blood glucose levels (hypoglycaemia)24 (21.8%)86 (78.2%)I'm afraid of injecting myself with a needle82 (74.5%)28 (25.5%)Taking insulin causes renal failure and blindness13 (11.8%)97 (88.2%)

We found that education level had a statistically significant association with fifth item of questionnaire "painful insulin injection" among patients (*P*=0.033, OR=0.357). In this way, having less education was correlated to this item. Patients age (*P*=0.025, OR=1.076) and disease duration (*P*=0.024, OR=0.231) were significantly associated with the eleventh question of questionnaire i.e. "taking insulin makes life less flexible". That means, older patients, as well as individuals with a disease duration of more than or equal to one year, more agree with the eleventh item of questionnaire i.e. (insulin therapy reduces the flexibility of life). There was no significant relationship between demographic variables and other 15 questions of the questionnaire.

2. Experimental design, materials and methods {#s0010}
=============================================

This cross-sectional study was carried using 110 patients with diabetes type 2 who referred to two endocrinology outpatient clinic affiliated to Islamic Azad University of Mashhad, Iran (IAUM) from January 2016 to September 2017. Convenience sampling was done in the study. They were selected while attending to clinic for follow-up of their disease. All participants gave oral consent before data gathering which was done by one clinician. Inclusion criteria were: T2DM patients had not received insulin, age≥18 years, poor glycemic control, HbA1c \>7.0%, oral glucose-lowering therapy, and patients who refused insulin therapy. Patients were excluded if they had T1DM, severe psychiatric illness, dementia, unstable cardiovascular disease, an existing debilitating medical condition, unwilling to give consent, and were on current insulin treatment.

Our tool for data gathering was a self-administered questionnaire developed by a group of endocrinologists and Community medicine specialists according to some studies agents [@bib2], [@bib3]. The questionnaire had two parts. In part one, general information including demographic and clinical data, such as age, gender, marital status, education level, drug history, family history of diabetes mellitus, duration of diabetes, fasting blood glucose (FBS) and HbA1c levels were obtained from the patients. In the second part, the questionnaire consisted of 17 items. We examined causes of unwillingness to use insulin. The answer to each question is in the form of two options, including agree and disagree. Face and content validity was confirmed by the experts. The Cronbach׳s alpha value for the questionnaire was 0.72. Also, in the test-retest method, the questionnaire was completed by 15 patients and again completed 2 weeks later by the same patients. For each question, the intra-class correlation coefficient was calculated and was higher than 0.9 for all of the items.

Statistical analyses were performed by SPSS version 16.0 software using descriptive and analytical tests. Multiple logistic regressions were used to study the association between cause of insulin therapy refusal and some variables including age, gender, marital status, education level, and disease duration. Reference category for variables was as follows; gender: female sex, educational status: less than diploma, marital status: single and for the duration of the illness: more than or equal to one year. Statistical significance was set at *P*\<0.05.

This study was reviewed and approved by the Medical Research Ethics Committee of IAUM. (Ethical Code: IR.IAU.MSHD.REC.1396.38).
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